entertainment -WSS

entertainment

author：leisure time 2025-10-01 18:07:43 - browse：45

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： FDA seeking to stop procedures at two unregulated stem cell clinics

WSS

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

White House finalizes ITC's import ban of latest Apple Watches

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Manchin plays down potential 3rd

A single drug, study failures leave Anavex with nothing but cash

hotspot

entertainment

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

United colonoscopy coverage change 'may cost lives,' doctors say

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

After affirmative action ruling, medical educators look to 'holistic review'

Goldman Sachs launches $650M fund for life science investments

Sports medicine is finally prioritizing gender equality

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

UCB departs biotech trade group BIO

hotspot

Why psychiatrists like me stop taking insurance

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

J&J to buy cancer drug developer Ambrx Biopharma

A Theranos scientist

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

3 trends to watch in health tech's hiring outlook for 2024

leisure time

explore

explore

hotspot